Kendall Law Group, led by former federal judge Joe Kendall, is investigating Catalyst Health Solutions, Inc. (NASDAQ: CHSI) for shareholders in connection with the proposed acquisition by SXC Health Solutions Corp. The national securities firm’s investigation seeks to determine whether Catalyst Health Solutions and its Board breached their fiduciary duties by entering into the agreement without properly shopping for a deal that would provide better value for shareholders. If you are a Catalyst Health Solutions shareholder and would like additional information about your rights, contact the Kendall Law Group at 877-744-3728 or by email at email@example.com.
On April 18, 2012, the companies announced the definitive merger agreement under which Catalyst Health Solutions would be acquired by SXC, in a transaction valued at approximately $4.4 billion. Under the terms of the agreement, Catalyst Health Solutions stockholders will receive $28.00 in cash and 0.6606 shares of SXC stock (NASDAQ: SXCI) for each share of Catalyst Health Solutions/CHSI common stock held. The firm’s investigation seeks to determine whether Catalyst Health Solutions and its Board undertook a fair process in negotiating the deal.
Kendall Law Group was founded by a former federal judge, includes a former United States Attorney, prosecutors and securities lawyers who are experienced in complex securities litigation. The firm has been counsel in numerous merger and acquisition cases nationwide, including some of the largest transactions in the United States.